A detailed history of Chicago Capital Management, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Chicago Capital Management, LLC holds 129,600 shares of VRNA stock, worth $13.9 Million. This represents 85.58% of its overall portfolio holdings.

Number of Shares
129,600
Holding current value
$13.9 Million
% of portfolio
85.58%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$90.08 - $106.69 $11.7 Million - $13.8 Million
129,600 New
129,600 $13.8 Million

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $6.52B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Chicago Capital Management, LLC Portfolio

Follow Chicago Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital Management, LLC with notifications on news.